| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.037 | 0.4 |